Your browser doesn't support javascript.
loading
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
Abdel-Aziz, Mahmoud I; Vijverberg, Susanne J H; Neerincx, Anne H; Brinkman, Paul; Wagener, Ariane H; Riley, John H; Sousa, Ana R; Bates, Stewart; Wagers, Scott S; De Meulder, Bertrand; Auffray, Charles; Wheelock, Åsa M; Bansal, Aruna T; Caruso, Massimo; Chanez, Pascal; Uddin, Mohib; Corfield, Julie; Horvath, Ildiko; Krug, Norbert; Musial, Jacek; Sun, Kai; Shaw, Dominick E; Sandström, Thomas; Montuschi, Paolo; Fowler, Stephen J; Lutter, René; Djukanovic, Ratko; Howarth, Peter; Skipp, Paul; Sanak, Marek; Adcock, Ian M; Chung, Kian Fan; Sterk, Peter J; Kraneveld, Aletta D; Maitland-van der Zee, Anke H.
Afiliación
  • Abdel-Aziz MI; Dept of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Vijverberg SJH; Dept of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
  • Neerincx AH; Dept of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Brinkman P; Dept of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Wagener AH; Dept of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Riley JH; Dept of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Sousa AR; Respiratory Therapeutic Unit, GlaxoSmithKline, Stockley Park, UK.
  • Bates S; Respiratory Therapeutic Unit, GlaxoSmithKline, Stockley Park, UK.
  • Wagers SS; Respiratory Therapeutic Unit, GlaxoSmithKline, Stockley Park, UK.
  • De Meulder B; BioSci Consulting, Maasmechelen, Belgium.
  • Auffray C; European Institute for Systems Biology and Medicine, CIRI UMR5308, CNRS-ENS-UCBL-INSERM, Lyon, France.
  • Wheelock ÅM; European Institute for Systems Biology and Medicine, CIRI UMR5308, CNRS-ENS-UCBL-INSERM, Lyon, France.
  • Bansal AT; Respiratory Medicine Unit, Dept of Medicine and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Caruso M; Dept of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.
  • Chanez P; Acclarogen Ltd, St John's Innovation Centre, Cambridge, UK.
  • Uddin M; Dept of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
  • Corfield J; Département des Maladies Respiratoires APHM, U1067 INSERM, Aix Marseille Université Marseille, Marseille, France.
  • Horvath I; AstraZeneca BioPharmaceuticals R&D, Gothenburg, Sweden.
  • Krug N; AstraZeneca R&D, Mölndal, Sweden.
  • Musial J; Areteva R&D, Nottingham, UK.
  • Sun K; Dept of Public Health, Semmelweis University; National Koranyi Institute for Pulmonology, Budapest, Hungary.
  • Shaw DE; Fraunhofer Institute for Toxicology and Experimental Medicine Hannover, Hannover, Germany.
  • Sandström T; Dept of Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Montuschi P; Data Science Institute, South Kensington Campus, Imperial College London, London, UK.
  • Fowler SJ; Respiratory Research Unit, University of Nottingham, Nottingham, UK.
  • Lutter R; Dept of Public Health and Clinical Medicine, Dept of Medicine, Respiratory Medicine Unit, Umeå University, Umeå, Sweden.
  • Djukanovic R; Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy.
  • Howarth P; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, and Manchester Academic Health Science Centre and NIHR Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manches
  • Skipp P; Dept of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Sanak M; Dept of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Adcock IM; NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences, and Human Development and Health, University of Southampton, Southampton, UK.
  • Chung KF; NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences, and Human Development and Health, University of Southampton, Southampton, UK.
  • Sterk PJ; Centre for Proteomic Research, Biological Sciences, University of Southampton, Southampton, UK.
  • Kraneveld AD; Dept of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Maitland-van der Zee AH; National Heart and Lung Institute, Imperial College London, and Royal Brompton and Harefield NHS Trust, London, UK.
Eur Respir J ; 59(1)2022 01.
Article en En | MEDLINE | ID: mdl-34824056
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Microbiota Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Respir J Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Microbiota Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Respir J Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos